Effect of Intrathecal Non-NMDA EAA Receptor Antagonist LY293558 in Rats: A New Class of Drugs for Spinal Anesthesia

Background Excitatory amino acid receptors are important for both sensory and motor function in the spinal cord. We studied the effects of intrathecal LY293558, a competitive non–N-methyl-d-aspartate excitatory amino acid receptor antagonist, on motor and sensory function in rats to determine whether drugs blocking these receptors could potentially be used as alternative agents to local anesthetics for spinal anesthesia. Methods Rats were tested before and 15–240 min after intrathecal injection of 5 nmol (in 10 &mgr;l) LY293558. Sensory function was tested at the hind paw using withdrawal response to pin prick and withdrawal to pinch with sharp forceps. Motor performance (ambulation, placing reflex, and Rotorod time), blood pressure, and heart rate were also evaluated. Some tests were repeated the next day. Responses after LY293558 were compared to injection of 40 &mgr;l bupivacaine, 0.75%. Pin-prick responses at the forepaw, chest, abdomen, hind leg, and hind paw were also examined after intrathecal LY293558. Results Intrathecal LY293558 blocked both sensory and motor responses through 180 min; complete recovery was present the following day. No change in blood pressure or heart rate occurred. The effects of LY293558 were more pronounced and sustained than those of bupivacaine. Segmental blockade of the response to pin prick was present after LY293558. Conclusion Drugs like LY293558 that block &agr;-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA)/kainate receptors may be an alternative to local anesthetics for spinal anesthesia in humans.

[1]  P. Branchereau,et al.  Development of lumbar rhythmic networks: from embryonic to neonate locomotor-like patterns in the mouse , 2000, Brain Research Bulletin.

[2]  Michael E. Johnson,et al.  Potential neurotoxicity of spinal anesthesia with lidocaine. , 2000, Mayo Clinic proceedings.

[3]  A. Saxena,et al.  Effects of intrathecal ketamine added to bupivacaine for spinal anaesthesia , 2000, Anaesthesia.

[4]  T. Brennan,et al.  Effect of Pretreatment with Intrathecal Excitatory Amino Acid Receptor Antagonists on the Development of Pain Behavior Caused by Plantar Incision , 2000, Anesthesiology.

[5]  T. Horlocker.  Complications of spinal and epidural anesthesia. , 2000, Anesthesiology clinics of North America.

[6]  T. Brennan,et al.  Lumbar catheterization of the subarachnoid space with a 32‐gauge polyurethane catheter in the rat , 2000, European journal of pain.

[7]  E. Hamber,et al.  Intrathecal lipophilic opioids as adjuncts to surgical spinal anesthesia. , 1999, Regional anesthesia and pain medicine.

[8]  R. Gracely,et al.  AMPA/Kainate Antagonist LY293558 Reduces Capsaicin‐evoked Hyperalgesia but Not Pain in Normal Skin in Humans , 1998, Anesthesiology.

[9]  T. Brennan.  AMPA/kainate receptor antagonists as novel analgesic agents. , 1998, Anesthesiology.

[10]  J. Eisenach,et al.  Spinal anesthesia: mechanisms, agents, methods, and safety. , 1998, Regional anesthesia and pain medicine.

[11]  P. Ornstein,et al.  Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat , 1998, Neuropharmacology.

[12]  T. Brennan,et al.  Intrathecal non-NMDA excitatory amino acid receptor antagonists inhibit pain behaviors in a rat model of postoperative pain , 1998, Pain.

[13]  M. Serpell,et al.  Intrathecal Anesthesia With Ketamine , 1997, Regional Anesthesia & Pain Medicine.

[14]  M. Corio,et al.  Immunocytochemical distribution of ionotropic glutamate receptor subunits in the spinal cord of the rabbit , 1996, Journal of Chemical Neuroanatomy.

[15]  R. Weinberg,et al.  AMPA Receptor Subunits Underlying Terminals of Fine-Caliber Primary Afferent Fibers , 1996, The Journal of Neuroscience.

[16]  N. K. Sckaran,et al.  Spinal ketamine anaesthesia for hemithyroidectomy , 1996, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[17]  B. Ballyk,et al.  Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid. , 1996, Molecular pharmacology.

[18]  S. Morrison,et al.  Medullary‐evoked EPSPs in neonatal rat sympathetic preganglionic neurones in vitro. , 1995, The Journal of physiology.

[19]  T. Coderre,et al.  The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests , 1994, Pain.

[20]  T. Yaksh.  Spinal somatostatin for patients with cancer. Risk-benefit assessment of an analgesic. , 1994, Anesthesiology.

[21]  P. Ornstein,et al.  (3SR,4aRS,6RS,8aRS)-6-[2-(1H-tetrazol-5-yl)ethyl]decahydroisoquinoline-3 - carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist. , 1993, Journal of medicinal chemistry.

[22]  H. Takagi,et al.  Region-specific expression of subunits of ionotropic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in the rat spinal cord with special reference to nociception. , 1993, Brain research. Molecular brain research.

[23]  L. Sorkin,et al.  The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  D. Reis,et al.  Rostral ventrolateral medulla: a source of the glutamatergic innervation of the sympathetic intermediolateral nucleus , 1991, Brain Research.

[25]  E. Perl,et al.  Selective excitation of neurons in the mammalian spinal dorsal horn by aspartate and glutamate in vitro: correlation with location and excitatory input , 1985, Brain Research.

[26]  J. Bion,et al.  Intrathecal ketamine for war surgery. A preliminary study under field conditions , 1983, Anaesthesia.

[27]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.

[28]  B. Bettler.  Review : Neurotransmitter Receptors II AMPA and Kainate Receptors , 2003 .

[29]  H. Lee.  Effects of Systemic and Intrathecal AMPA/KA Receptor Antagonist LY293558 in a Rat Model for Postoperative Pain , 2000 .